Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety of PD-1 knockout engineered T cells in treating metastatic non-small cell lung cancer. Blood samples will also be collected for research purposes.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sichuan University
Collaborators
NCT07227298 · Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, and more
NCT06417814 · Metastatic Non-small Cell Lung Cancer
NCT07154290 · Advanced/Metastatic Non-Small Cell Lung Cancer
NCT06996782 · Advanced or Metastatic Non-small Cell Lung Cancer
NCT06975293 · Metastatic Non-small Cell Lung Cancer, Metastatic Melanoma, and more
West China Hospital, Sichuan University
Chengdu, Sichuan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions